Conflict Expression Tendencies in Workgroups: Measure Validation and a Test of Theory
Small Group Research · 11.06.2026
DOI: 10.1177/10464964261448469 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small Group Research, online erschienen am 11.06.2026. Verfasst von Yeonjeong Kim und 7 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 119 Literaturangaben.
Abstract (Originalsprache)
Building on conflict expression theory, we develop and validate a measure of workgroup conflict expression tendencies (the “CET” measure). The CET is comprised of four dimensions—Argue, Debate, Subvert, and Disguise—defined by the directness and intensity of expressed opposition. Across six studies with diverse samples, the measure shows strong psychometric properties and convergent, discriminant, criterion, and incremental validity. Conflict expression tendencies relate appropriately to adjacent constructs, are distinct from conflict types (task, process, relationship) and management strategies, and explain incremental variance in trust, emotions, and information acquisition. We conclude with directions for future research on conflict expression in groups.
Zitieren
APA
Kim, Y., Weingart, L. R., Bendersky, C., Behfar, K., Todorova, G., Bear, J., Jehn, K., & Miron-Spektor, E. (2026). Conflict Expression Tendencies in Workgroups: Measure Validation and a Test of Theory. Small Group Research. https://doi.org/10.1177/10464964261448469
Vancouver
Kim Y, Weingart LR, Bendersky C, Behfar K, Todorova G, Bear J, et al. Conflict Expression Tendencies in Workgroups: Measure Validation and a Test of Theory. Small Group Research. 2026. doi:10.1177/10464964261448469
BibTeX
@article{Kim2026,
author = {Kim, Yeonjeong and Weingart, Laurie R. and Bendersky, Corinne and Behfar, Kristin and Todorova, Gergana and Bear, Julia and Jehn, Karen and Miron-Spektor, Ella},
title = {Conflict Expression Tendencies in Workgroups: Measure Validation and a Test of Theory},
journal = {Small Group Research},
year = {2026},
doi = {10.1177/10464964261448469}
}
EUVIMED